RVTY
REVVITY, INCNYSEResearch view
Healthcare · Laboratory Analytical Instruments · Large-cap · SEC EDGAR FY 2025-12-28
Price history
Chart: TradingView’s own feed · page prices: 1D EOD🔒 Click to interact · scroll moves the page
Snapshot
SEC EDGAR · FY 2025-12-28SectorHealthcare
Market Cap$16.0B
Enterprise Value$18.3B
Income$241.2M
Sales$2.9B
Book/sh$64.98
Cash/sh$8.25
Dividend TTM$0.28
Payout14%
Employees—
IPO—
Quick Ratio1.40
Current Ratio1.68
Debt/Eq0.44
EPS (ttm)$2.07
EPS this Y-5.9%
EPS past 3/5Y-22.8%
Sales past 3/5Y-4.8%
EPS Y/Y TTM-5.9%
Sales Y/Y TTM3.7%
Shs Outstand111.59M
ROA2.0%
ROE3.3%
ROIC3.3%
Gross Margin—
Oper. Margin12.5%
Profit Margin8.4%
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.
Revenue & Earnings — fiscal year
$3.8B
2022
$3.3B
2023
$2.8B
2023
$2.8B
2024
$2.9B
2025
Financials — annual
SEC EDGAR · last 5 FY · tap a row to explain it| USD | FY2022 | FY2023 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $3.8B | $3.3B | $2.8B | $2.8B | $2.9B |
| Gross Profit | $2.4B | $2.0B | — | — | — |
| Operating Income | $1.3B | $742.7M | $300.6M | $346.7M | $356.6M |
| Net Income | $943.2M | $569.2M | $693.1M | $270.4M | $241.2M |
| Diluted EPS | $8.08 | $4.50 | $5.55 | $2.20 | $2.07 |
| Operating Cash Flow | $1.4B | $679.8M | $91.3M | $628.3M | $582.9M |
| Free Cash Flow | $1.3B | $594.2M | $9.9M | $541.7M | $509.4M |
Deep dive
Computed from the SEC EDGAR multi-year statementsOperating leverage — margins
GrossOperatingNet
FY25 cash-flow waterfall
Capital-light: capex is $73.5M against $582.9M operating cash
COMMUNITY · $RVTY0 theses
POST YOUR TAKE →Related Stocks
Click to exploreSame Industry · Laboratory Analytical Instruments
Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.